rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Joseph L. Farmer

Officer

Company insider

Files Form 4 as: Officer, Zenas BioPharma; Sr VP, Gen Counsel & Secretary, Tesaro; General Counsel, SVP, Amag Pharmaceuticals.

In numbers

Trades disclosed
65
Buys
0
Sells
10
Bought
$0
Sold
$1.5M
Companies
3
Companies where not an officer
0
First trade
8 Mar 2005
Last trade
15 Jun 2026
Last filed
17 Jun 2026

Companies traded

Where they are an officer
ZBIO Zenas BioPharmaOfficer · Biotechnology · last 15 Jun 20260 buys · 0 sells
TesaroOfficer · last 22 Jan 20190 buys · 3 sells
Amag PharmaceuticalsOfficer · last 24 Feb 20120 buys · 7 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jun 2026filed 17 Jun 2026ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—175,000 at $0.00filing
15 Jun 2026filed 17 Jun 2026ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—175,000 at $0.00filing
5 Feb 2026filed 17 Jun 2026ZBIO Zenas BioPharmaBiotechnologySEC FORM 4 Code A$13K974 at $13.35filing
5 Feb 2026filed 17 Jun 2026ZBIO Zenas BioPharmaBiotechnologySEC FORM 4 Code A$13K974 at $13.35filing
10 Jun 2025filed 12 Jun 2025ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—175,000 at $0.00filing
12 Sep 2024filed 16 Sep 2024ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—206,000 at $0.00filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—8,750filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—1,250filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—4,447filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—18,182filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—75,000filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—35,000filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—10,782filing
22 Jan 2019filed 22 Jan 2019Tesarooption or derivativeSEC FORM 4 Code D—31,954filing
22 Jan 2019filed 22 Jan 2019TesaroSEC FORM 4 Code U$703K9,367 at $75.00filing
1 Aug 2018filed 3 Aug 2018Tesarooption or derivativeSEC FORM 4 Code M—625 at $0.00filing
1 Aug 2018filed 3 Aug 2018TesaroSEC FORM 4 Code M—625 at $0.00filing
1 Aug 2018filed 3 Aug 2018TesaroSEC FORM 4 Sold$6,427187 at $34.37filing
2 Mar 2018filed 5 Mar 2018TesaroSEC FORM 4 Sold$145K2,634 at $54.86filing
1 Mar 2018filed 5 Mar 2018TesaroSEC FORM 4 Code M—4,375 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed10

Buys in green, sells in red, by the company’s sector.

Related people

Christy J. OligerDirector · Director at Zenas BioPharma, filing Form 4 there in the last year
Patrick G. EnrightDirector · Director at Zenas BioPharma, filing Form 4 there in the last year
Patricia L. AllenDirector · Director at Zenas BioPharma, filing Form 4 there in the last year
Jason Raleigh NunnDirector · Director at Zenas BioPharma, filing Form 4 there in the last year
John J. OrloffDirector · Director at Zenas BioPharma, filing Form 4 there in the last year